Endur-acin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Endur-acin
R
- Rapamune (sirolimus)
- Rasuvo (methotrexate)
- Rebif (interferon beta-1a)
- Rebif Rebidose (interferon beta-1a)
- Recorlev (levoketoconazole)
- red yeast rice
- RediTrex (methotrexate)
- Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular)
- Relion Novolin N (insulin isophane)
- ReliOn NovoLog (insulin aspart)
- ReliOn/Humulin R (insulin regular)
- ReliOn / Novolin 70 / 30 (insulin isophane / insulin regular)
- ReliOn/Novolin R (insulin regular)
- remdesivir
- repaglinide
- Retrovir (zidovudine)
- Revia (naltrexone)
- Rexolate (sodium thiosalicylate)
- Rezulin (troglitazone)
- Rezvoglar (insulin glargine)
- Rheumatrex Dose Pack (methotrexate)
- Rhinocaps (acetaminophen / aspirin / phenylpropanolamine)
- Rifadin (rifampin)
- Rifadin IV (rifampin)
- Rifamate (isoniazid / rifampin)
- rifampin
- Rifater (isoniazid / pyrazinamide / rifampin)
- Rimactane (rifampin)
- Riomet (metformin)
- Riomet ER (metformin)
- Robaxisal (aspirin / methocarbamol)
- Roctavian (valoctocogene roxaparvovec)
- rosiglitazone
- rosuvastatin
- Roszet (ezetimibe / rosuvastatin)
- Roxiprin (aspirin / oxycodone)
- Rybelsus (semaglutide)
- Rylaze (asparaginase erwinia chrysanthemi)
- Ryzodeg 70/30 (insulin aspart/insulin degludec)
More about Endur-acin (niacin)
- Endur-acin consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.